Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

Fig. 3

ABCB5+ MSCs alleviated hypoxia-induced ROS burden in HUVECs. A, B HUVECs expressing roGFP3 were treated with 80 μM CoCl2, or 120 μM DFO or 100 μM H2O2 in medium for 4 h. H2O2 was used as positive control. Thereafter, HUEVCs were either co-cultured with ABCB5+ MSCs (CoCl2-CO; DFO-CO) or cultured in ABCB5+ MSC-CM (CoCl2-CM; DFO-CM) for 24 h. The ratio of florescence intensity Ex 395 nm and at Ex 485 nm, and the emission at 520 nm was measured by a Tecan multimode reader every 2 h and ratio was calculated. A ROS changes in HUVECs treated by CoCl2, CoCl2-CM and CoCl2-CO treatments; B DFO, DFO-CM and DFO-CO treatments. Data is represented as mean ± SD, n = 3 in each group

Back to article page